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Coxiella burnetii is an intracellular pathogen that replicates in a
lysosome-like vacuole through activation of a Dot/Icm-type IVB se-
cretion system and subsequent translocation of effectors that re-
model the host cell. Here a genome-wide small interfering RNA
screen and reporter assay were used to identify host proteins re-
quired for Dot/Icm effector translocation. Significant, and indepen-
dently validated, hits demonstrated the importance of multiple
protein families required for endocytic trafficking of the C. burnetii-
containing vacuole to the lysosome. Further analysis demonstrated
that the degradative activity of the lysosome created by proteases,
such as TPP1, which are transported to the lysosome by receptors,
such as M6PR and LRP1, are critical for C. burnetii virulence. Indeed,
the C. burnetii PmrA/B regulon, responsible for transcriptional up-
regulation of genes encoding the Dot/Icm apparatus and a subset
of effectors, induced expression of a virulence-associated transcrip-
tome in response to degradative products of the lysosome. Lucifer-
ase reporter strains, and subsequent RNA-sequencing analysis,
demonstrated that particular amino acids activate the C. burnetii
PmrA/B two-component system. This study has further enhanced
our understanding of C. burnetii pathogenesis, the host–pathogen
interactions that contribute to bacterial virulence, and the different
environmental triggers pathogens can sense to facilitate virulence.
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Coxiella burnetii, the causative agent of human Q fever, is animportant zoonotic pathogen. Inhalation of contaminated
aerosols, commonly through exposure to infected animals, can
cause an acute systemic infection frequently involving pneumo-
nia or hepatitis (1). A small proportion of infected individuals
will develop persistent chronic Q fever with life-threatening com-
plications such as endocarditis.
Following inhalation, the bacteria infect alveolar macrophages
and replicate to high numbers within these cells (2, 3). The in-
tracellular niche of C. burnetii is a unique, spacious vacuole termed
the Coxiella-containing vacuole (CCV). The C. burnetii-containing
phagosome undergoes endocytic trafficking to mature into the
normally bactericidal lysosome where conditions stimulate C.
burnetii metabolism and biogenesis of the CCV (4). The CCV
retains the low pH and hydrolytic features of a lysosome but is
also modified by the pathogen to facilitate replication. Key fea-
tures of the mature CCV include significant expansion, through
interaction with intracellular vesicles including autophagosomes,
clathrin-coated vesicles, and endocytic vesicles, and a strong
antiapoptotic influence on the host cell (5, 6).
Recently, the development of methods to axenically cultivate
and genetically manipulate C. burnetii has led to a revolution in
the capacity to explore the molecular details of the host–pathogen
interactions mediated by C. burnetii (7–9). Multiple mutagenesis
studies have confirmed that intracellular replication of C. burnetii,
and therefore virulence, requires a functional Dot/Icm-type IVB
secretion system (10–14). This specialized secretion apparatus allows
the pathogen to introduce a large repertoire of effector proteins into
the host cytosol. Although the biochemical functions of individual
effectors are poorly understood, it is clear that these effectors work
in concert to manipulate host cell processes and create the repli-
cative niche while still maintaining host cell homeostasis (5).
The C. burnetiiDot/Icm system is functionally analogous to the
well-studied Dot/Icm system of Legionella species, which is essen-
tial for intracellular replication of Legionnaires’ disease-causing
pathogens (15). Despite depending on the same apparatus for
virulence, the replicative niches of Legionella and C. burnetii are
quite divergent. Legionella species actively evade the endocytic
pathway, with the Legionella-containing vacuole (LCV) acquiring
markers of the endoplasmic reticulum and secretory pathway
rapidly following phagocytosis (16). The distinct vacuolar destina-
tions of these closely related pathogens are mediated by the unique
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repertoires of Dot/Icm effectors and the exquisite control each
pathogen has over Dot/Icm activation. The Legionella Dot/Icm
system must be active immediately upon contact with a eukaryotic
cell to prevent endocytic maturation of the LCV. Indeed,
Legionella pneumophila effector translocation occurs upon in-
timate contact with the host plasma membrane even when entry is
blocked (17). In contrast, C. burnetii effector translocation is
delayed until the pathogen reaches the acidic confines of the ly-
sosome (18). Silencing expression of endocytic Rab GTPases Rab5
or Rab7 or chemically disrupting lysosome acidification with the
vacuolar ATPase inhibitor Bafilomycin A leads to a significant
reduction in C. burnetii effector translocation (18, 19). This has
been demonstrated using a reporter assay where C. burnetii has
been engineered to constitutively express β-lactamase (BlaM)
transcriptionally fused to an effector and BlaM activity in the host
cytosol is measured as a proxy for effector translocation (19). Ex-
pression of Dot/Icm apparatus genes and a cohort of Dot/Icm
effectors is controlled by the PmrA/B two-component regulatory
system in both C. burnetii and L. pneumophila (20, 21). This system
is essential for C. burnetii intracellular replication, indicating that
transcriptional control is integral to Dot/Icm activation (13, 14, 21).
Here the robust β-lactamase reporter assay and delayed effector
translocation by C. burnetii have been harnessed as a tool to define
human host factors that contribute to both bacterial transport to a
lysosome in general and the specific environmental conditions
within the lysosome that signal C. burnetii, through PmrA/B, to
trigger virulence. This study has significantly advanced under-
standing of C. burnetii pathogenesis and the importance of various
host systems in developing its intracellular niche.
Results
Genome-Wide Small Interfering RNA Screen of Host Genes Necessary
for Efficient C. burnetii Dot/Icm Effector Translocation. Previous
work established the importance of the host endocytic pathway
for efficient effector translocation by C. burnetii (18, 22). To
globally elucidate the host genes required for C. burnetii effector
translocation, and therefore virulence, a high-throughput genome-
wide small interfering RNA (siRNA) screen was performed (Fig.
1A). Effector translocation was examined using a reporter C.
burnetii Nine Mile phase II (NMII) strain constitutively expressing
the known effector protein MceA (10, 23) with an N-terminal
BlaM fusion and the fluorescent BlaM substrate CCF2-AM.
Following excitation at 410 nm, cleavage of CCF2-AM by BlaM
leads to a shift in fluorescence emission from 520 nm (green) to
450 nm (blue). The 450:520-nm ratio was used to assess BlaM–
MceA translocation into the host cytosol.
HeLa cells were transfected with an siRNA SMARTpool li-
brary targeting 18,120 individual protein-coding genes in a 96-well
plate-arrayed format for 72 h and then infected with C. burnetii
NMII pBlaM–MceA. Effector translocation was measured 24 h
postinfection using the fluorescent substrate CCF2-AM prior to
fixation and high-content imaging quantification of cell viability
within individual wells using the nuclear stain DRAQ5. Controls
were used on each 96-well plate to assess transfection efficiency
and assay robustness. Both mock-transfected cells, delivered lipid
but no siRNA, and ON-TARGET plus-nontargeting control
(siOTP-NT) SMARTpool were used as negative controls (24).
Cells transfected with the siRab7A SMARTpool were used as a
positive control for the reduction of effector translocation, and
cells transfected with the siPLK1 (polo-like kinase 1) SMART-
pool were used as a transfection control since depletion of PLK1
results in cell death (25).
The standard hit-identification approach for siRNA screens is
the application of a robust Z-score normalization across all screen
plates (26, 27). Z-score normalization to siOTP-NT revealed 82
and 968 genes for which the translocation ratio was significantly
decreased or increased, respectively (Dataset S1). The decrease in
translocation ratio observed within the 82 genes ranged from 76 to
62% compared with siOTP-NT. The average translocation ratio
reduction across all screened plates for the siRab7A SMARTpool
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Fig. 1. Genome-wide siRNA screen of host genes necessary for efficient C. burnetii Dot/Icm effector translocation. (A) Summary of the overall siRNA screen
including hit selection and confirmed targets. (B) Pie chart displaying the overall outcome from the deconvoluted validation screen of the selected 400
targets. (C) Enrichment analysis of the biological process categories that were overrepresented in the 251 validated targets using the PANTHER over-
representation test against the Homo sapiens genome reference list.
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control was 56.5 ± 7.5% compared with siOTP-NT. Since the
focus of this study was the identification of host proteins that
adversely affected effector translocation, the majority of the 400
genes selected for the secondary validation screen demonstrated
at least a 25% reduction in translocation relative to siOTP-NT.
Included in this cohort were 53 out of the possible 82 genes that
had demonstrated a statistically significant decrease in trans-
location (Dataset S2). The impact of individual siRNA treatment
on cell viability was also considered during target selection for the
secondary screen. More than 50% cell viability was considered
acceptable. Since the assay readout is ratiometric, results were
minimally affected by changing cell numbers. Targets with >50%
toxicity following the secondary screen were not considered for
any follow-up analysis.
The validation screen of 400 selected targets was performed
using the same assay format as the primary screen; however, the
siRNA SMARTpools were deconvoluted and the four individual
duplex siRNAs were screened separately. Defining the level of
confidence in validation of selected targets was determined by
approximate reproduction of the translocation ratio observed
during the primary screen and a minimum decrease in effector
translocation of 20% compared with siOTP-NT (Fig. 1B and
Dataset S3). Using this classification, 117 genes validated with
high confidence (3/4 or 4/4 siRNAs), 134 genes with moderate
confidence (2/4 siRNAs), and 149 genes did not validate (1/4 or 0/4
siRNAs) (Dataset S3). Enrichment analysis of the validated 251
using the PANTHER classification system (28) revealed biological
process categories that were statistically overrepresented (Fig. 1C
and SI Appendix, Table S1).
Genome-Wide Screen Validates the Importance of the Host Endocytic
Trafficking Pathway for C. burnetii Infection. This screen demon-
strated that host proteins involved in the endocytic pathway,
including the Rab and SNARE (soluble NSF attachment protein
receptor) protein families and vacuolar protein-sorting (VPS)
proteins, are required for efficient effector translocation by C.
burnetii. Validated targets included key regulators of membrane
transport (including RAB5A and RAB7A) and the Rab protein
modifier RABGGTA (29, 30). The strongest hit from the pri-
mary screen, NAPA (alpha-soluble NSF attachment protein, also
known as SNAP-α), validated with high confidence together with
NAPB (beta-soluble NSF attachment protein; SNAP-β) and NSF
(N-ethylmaleimide–sensitive factor), which act together to ma-
nipulate SNARE proteins during vesicle-mediated transport
(31–33). Components of the eukaryotic retromer complex also
validated strongly, including those of the core complex (VPS29
and VPS35) and the cargo adapters, also known as sorting nexins
(SNX1, SNX3, and SNX6) (34, 35). These components were
previously identified in the siRNA screen by McDonough et al.
(22), who investigated the impact of silencing gene expression of
host proteins on C. burnetii replication. Our data confirm that
the retromer complex plays an important role in establishment of
C. burnetii infection. Proteins involved in the ESCRT (endo-
somal sorting complexes required for transport) complexes were
important, including VPS4B and VPS25 (36, 37), and SNARE
proteins whose functions have not been fully elucidated were
also identified, such as SNX22 and SNX24, suggesting a poten-
tial role for these proteins in endocytic trafficking.
In addition to a requirement for endocytic trafficking, C.
burnetii also exploits the eukaryotic autophagy pathway to es-
tablish its replicative niche (38, 39). The importance of this host
pathway was confirmed in the primary screen since a third of the
known autophagy family members (11 out of 33) produced an
observable translocation defect when silenced (Dataset S1). Five
of these members were further examined in the validation screen,
of which three were validated (ATG4B and ATG5 [moderate
confidence] and ATG12 [high confidence]; Dataset S3). The
identification of two members of the Atg5–Atg12–Atg16 complex,
which has an integral role in the autophagic process within the
host (40), highlights the importance of autophagy during estab-
lishment of C. burnetii infection.
Lysosomal Proteins Are Necessary for Efficient Effector Translocation
by C. burnetii. The C. burnetii replicative niche is a bacterially
modified lysosome that maintains an acidic pH and the presence
of lysosomal enzymes and membrane proteins (41, 42). Given
this lysosomal niche, primary screen results for proteins pre-
viously confirmed as resident lysosomal proteins (43) were ana-
lyzed (SI Appendix, Table S2). Of the 184 lysosomal proteins
assessed, silencing of 72 led to a decrease in effector trans-
location of at least 20% compared with siOTP-NT–treated cells,
demonstrating the significance of the lysosomal environment in
triggering C. burnetii virulence.
A subset of 23 lysosomal targets were tested in the validation
screen, of which 13 validated with either high or moderate confi-
dence (S1 Appendix, Table S2). These included vacuolar ATPase
subunits (ATP6V0C and ATP6V1E1) responsible for acidification
of the lysosome (44), and several lysosomal enzymes, including the
hydrolases cathepsin B (CTSB) and cathepsin C (CTSC), sialidase-1
(NEU1), and beta-mannosidase (MANBA). Additionally, lysosomal
transporters confirmed in the validation screen to be important for
bacterial effector translocation included the cholesterol transporters
Niemann–Pick C1 (NPC1) and Niemann–Pick C2 (NPC2), a
sodium-independent sulfate anion transporter (SLC26A11),
and the lysosomal cysteine transporter cystinosin (CTNS).
Given that gene silencing of so many lysosomal proteins led to
reduced Dot/Icm protein translocation, the ability of the cell to
deliver these proteins to the lysosome should also be required.
The majority of these proteins acquire mannose-6-phosphate
(Man-6-P) moieties that are recognized by either cation-dependent
or cation-independent Man-6-P receptors (M6PRs) enabling
transport to the lysosome (45), although several alternative re-
ceptors that enable the sorting of lysosomal enzymes indepen-
dent of Man-6-P have also been identified (46). Thus, the
dependence of effector translocation on a subset of recognized
lysosomal trafficking receptors identified in the primary siRNA
screen was investigated further (Fig. 2A). A decrease in effector
translocation was consistently observed for low-density lipopro-
tein receptor-related protein 1 (LRP1) and cation-dependent
M6PR (Fig. 2A). Simultaneous depletion of LRP1 and M6PR
resulted in a significant reduction of effector translocation compared
with siOTP-NT–treated cells (Fig. 2B). Importantly, no toxic effects
due to siRNA treatment were observed for all selected targets (SI
Appendix, Fig. S1 A and B). These data reiterate the importance of a
functional lysosomal environment for C. burnetii virulence.
The Role of Lysosomal Receptors LRP1 and M6PR during C. burnetii
Infection.Given the integral role of receptors LRP1 and M6PR in
lysosomal biogenesis (46) and the impact silencing expression of
these receptors had on C. burnetii effector translocation (Fig. 2 A
and B), further examination of LRP1 and M6PR depletion was
undertaken. Initially, the degradative capacity of lysosomes in
siRNA-treated cells was determined using the DQ Green BSA
reporter. The DQ-BSA (Dye Quenched-BSA) reporter is labeled
with the fluorophore BODIPY FL, resulting in self-quenching of
the dye. The molecule is endocytosed and accumulates in the ly-
sosome, where proteases hydrolyze DQ Green BSA into smaller
peptides, dequenching the dye and increasing fluorescence that
can be detected using a fluorescence plate reader (47). The ac-
tivity of lysosomal proteases is proportional to the rate of fluores-
cence increase. Individually silencing LRP1 andM6PR demonstrated
a trend toward decreased hydrolytic activity and silencing expression
of both led to a significant reduction in the degradative capacity of
the lysosome compared with siOTP-NT–treated cells (Fig. 2C). This
decrease was not as severe as siRab7A-treated cells (in which lyso-
somal biogenesis is inhibited) or in siOTP-NT cells treated with the
Newton et al. PNAS | March 24, 2020 | vol. 117 | no. 12 | 6803
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lysosomotropic agent chloroquine (Fig. 2C), suggesting that the
degradative capacity of lysosomes in LRP1/M6PR-deficient cells is
not completely abolished.
Since simultaneous depletion of both LRP1 and M6PR sig-
nificantly impacted the lysosomal degradative capacity of treated
cells, the impact on C. burnetii virulence was investigated further.
Western blot analysis confirmed almost complete abolishment of
protein expression of both LRP1 and M6PR in siLRP1/siM6PR-
treated cells (Fig. 2D). To eliminate a role for bacterial entry,
differential intracellular/extracellular staining of C. burnetii was
performed and no decrease in bacterial ingress was observed
compared with siOTP-NT–treated cells (SI Appendix, Fig. S1F).
Similarly, the capacity of C. burnetii to traffic through the host
endocytic pathway to the lysosome-like compartment required
for effector translocation may have been compromised. To assess
this possibility, siRNA-treated HeLa cells were infected with C.
burnetii for 6 h and the association of at least 150 internalized
bacteria with the lysosomal marker LAMP-1 was quantified per
experiment using fluorescence microscopy (SI Appendix, Fig.
S1H). No difference in LAMP-1 association was observed during
simultaneous silencing of LRP1 andM6PR. To ascertain whether
silencing LRP1 and M6PR influenced C. burnetii replication, the
CCV area was measured in siRNA-treated HeLa cells infected
with C. burnetii for 3 d (Fig. 2E). Micrograph images (Fig. 2F)
captured 3 d postinfection were used to determine the area of
CCVs (Fig. 2E). Surprisingly, a significant reduction in CCV size
was observed (mean CCV area, 38.25 ± 1.56 μm2) in siLRP1/
siM6PR-treated cells compared with siOTP-NT treatment
(58.25 ± 1.62 μm2) (Fig. 2E). This decrease did not translate to a
defect in bacterial replication, quantified by measuring the C.
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Fig. 2. Examination of the role of the lysosomal receptors LRP1 and M6PR and lysosomal protease TPP1 during C. burnetii infection. (A and B) Effector
translocation was determined using CCF2-AM in HeLa cells infected with C. burnetii pBlaM–MceA following transfection with siRNA SMARTpools for 72 h.
Results are expressed relative to the nontargeting control (siOTP-NT), with error bars indicating SEM from at least three independent experiments. Statistical
difference between tested siRNA and siOTP-NT was determined using one-way ANOVA, followed by Dunnett’s multiple-comparison posttest on raw data.
****P = 0.0001, *P < 0.05. The dotted lines indicate a translocation ratio of 0.8 relative to siOTP-NT. The outcome from the automated primary screen (circle)
is shown for comparison in A. (C) Lysosomal protease activity of HeLa cells transfected with siRNA SMARTpools for 72 h was determined using DQ Green BSA.
Results are expressed as the average linear rate of DQ-BSA hydrolysis for each condition (12 wells in a 96-well plate) over 2 h from at least three independent
experiments. Error bars denote SEM. Statistical difference between tested siRNA and siOTP-NT was determined using an unpaired, two-tailed t test on raw
data. CQ, chloroquine. (D) Immunoblot analysis of cell lysates from HeLa cells treated with siRNA SMARTpools collected at 24, 72, and 96 h post siRNA
treatment. The absence of protein expression in siRNA-treated cells compared with siOTP-NT–treated cells was confirmed using anti-LRP1 (Top) and anti-M6PR
(Middle) antibodies. Anti–β-actin was used as a loading control (Bottom). (E) Intracellular replication of C. burnetii in HeLa cells treated with siRNA
SMARTpools and subsequently infected with C. burnetii at an MOI of 50 for 3 d. Results are expressed as the average CCV area (μm2) from four experiments
with at least 50 CCVs measured per experiment. Error bars represent SEM. Statistical difference between siOTP-NT and tested siRNA was determined using an
unpaired, two-tailed t test on raw data. (F) Representative confocal micrograph images of siRNA-treated HeLa cells infected for 3 d with C. burnetii used to
quantify CCV area in E. Cells were stained with anti-Coxiella antibody (red), anti–LAMP-1 antibody (green), and DAPI (blue). (Scale bars, 10 μm.) Asterisks
indicate CCV. (G) Immunoblot analysis of cell lysates from HeLa parent cells and LRP1 KO cells (Top), M6PR KO cells (Middle), and TPP1 KO cells (Bottom)
illustrating the absence of protein expression in the KO cells using anti-LRP1, anti-M6PR, and anti-TPP1 antibodies, respectively. Anti–β-actin was used as a
loading control. (H and I) Effector translocation was measured in KO cell lines infected with either C. burnetii pBlaM–MceA (H) or C. burnetii pBlaM–Cig2 (I).
Results are expressed relative to HeLa cells, with error bars denoting SEM from three independent experiments. Statistical difference between HeLa and KO
cell lines was determined using one-way ANOVA, followed by Dunnett’s multiple-comparison posttest on raw data.
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burnetii genome equivalents (SI Appendix, Fig. S1J). Collectively,
these data suggest that while progression to the lysosome-like
compartment and bacterial replication are not impacted during
simultaneous silencing of LRP1 and M6PR, expansion of the
spacious replicative vacuole is significantly affected by the absence
of both of these proteins. Importantly, analysis following a single
siRNA treatment did not recapitulate this smaller CCV pheno-
type (SI Appendix, Fig. S1 K and L). This provides further evi-
dence uncoupling the reduced translocation phenotype from CCV
expansion, indicating that the overall degradative capacity of the
CCV influences vacuole size independent of Dot/Icm efficiency.
The M6PR-Dependent Lysosomal Protease TPP1 Is Required for
Efficient Dot/Icm Effector Translocation. Similar translocation de-
fects were observed following depletion of LRP1, M6PR, or both
receptors (Fig. 2 A and B), despite differential impact on overall
lysosomal degradative capacity (Fig. 2C). This suggested that
translocation efficiency is influenced by delivery and subsequent
activity of specific lysosomal proteins rather than the overall lyso-
somal environment. Indeed, this hypothesis is supported by the
genome-wide siRNA screen, where silencing expression of 39% of
lysosomal proteins caused a significant drop in C. burnetii effector
translocation (SI Appendix, Table S2). To further validate the role
of individual lysosomal enzymes in effector translocation, the ly-
sosomal serine protease TPP1 was also investigated.
TPP1 (tripeptidyl peptidase 1, also known as CLN2) is selec-
tively transported to the lysosome by the lysosomal receptor
M6PR (48), where it generates tripeptides from degraded pro-
teins within the lysosome (49). The generation of HeLa cell lines
completely devoid of either LRP1, M6PR, or TPP1 was pursued
using the CRISPR-Cas9 genome-editing system. HeLa cells
transfected with constructs that expressed guide RNA targeting
LRP1, M6PR, or TPP1 resulted in LRP1, M6PR, and TPP1
knockout (KO) cell lines with verified loss of each protein (Fig.
2G). Using the BlaM reporter fused to MceA, we observed a
reduction in effector translocation in both M6PR and TPP1 KO
cell lines of 60 and 55%, respectively, compared with the parent
cell line (Fig. 2H). The LRP1 KO cell line did not reproduce the
phenotype observed during siRNA treatment, indicating possible
adaptation to loss of this receptor (Fig. 2H). To verify that the
changes in translocation were not effector-specific, we also
tested another known effector of the Dot/Icm secretion system
(Cig2) (13), which produced similar results (40% reduction in
M6PR KO and 30% reduction in TPP1 KO) (Fig. 2I).
Lysosomal Breakdown of Cellular Material Is Required for Effector
Translocation and Virulence of C. burnetii. The siRNA screen in-
dicated that gene silencing of several lysosomal proteases led to
reduced effector translocation and the importance of this pro-
teolysis was validated by the TPP1 KO cell line. This led to the
hypothesis that protein degradation, and the subsequent prod-
ucts of this breakdown, may act as a signal to C. burnetii that the
environment is appropriate for Dot/Icm activity. To test this
hypothesis, effector translocation was examined following in-
duction of autophagy to increase the amount of cellular material
delivered to the lysosome. HeLa cells were infected with C.
burnetii pBlaM–MceA for 20 h and then starved in Hank’s bal-
anced salt solution (HBSS) for 4 h or left untreated. Under
starvation conditions, with increased autophagy, effector trans-
location was significantly increased (P = 0.0067) compared with
untreated cells (Fig. 3A). This difference was abolished in the
M6PR KO cell line (Fig. 3A). These data support the hypothesis
that C. burnetii Dot/Icm effector translocation relies on delivery
of the pathogen to a fully functional degradative compartment.
Expression of the Dot/Icm secretion apparatus genes as well as
a subset of effector genes is regulated by the PmrA/B two-
component system (20, 21). In other bacteria, the PmrB response
regulator is activated by changes in pH or the concentration of
Mg2+, Fe3+, or Al3+ cations (50). However, the activating signal
for the C. burnetii PmrA/B two-component system has not been
previously identified. In order to determine specific activators
of PmrA/B-dependent gene expression, bacterial luciferase re-
porter strains (12, 21) were constructed using the strong consti-
tutive promoter from cbu0311 (12) and the PmrA-regulated
icmW and cig2 promoters (21). Light production from the
cbu0311, icmW, and cig2 promoters was measured in axenic C.
burnetii cultures grown in complete ACCM-2 medium and then
transferred into medium where the pH was adjusted or the
medium composition had been altered as indicated (SI Appendix,
Fig. S2). Modifications to pH resulted in similar changes among
all promoters tested, indicating that transcriptional changes were
not PmrA/B-specific. Similarly, no PmrA/B-dependent changes
were observed with removal of specific components of ACCM-2,
substitution with spent culture medium at various ratios, nor
changes to cation concentration (SI Appendix, Fig. S2). This in-
dicated that the lysosomal PmrB-activating signal was unlike that
of related two-component systems.
Given the link between C. burnetii effector translocation and
lysosomal protease activity (Figs. 2 H and I and 3A), a possible
PmrA/B activation signal could be small peptides and/or amino
acids within the lysosome. To investigate this, the same luciferase-
expressing strains were grown axenically for 72 h and spiked with
individual amino acids (10 mM diluted in H2O) and light pro-
duction was monitored at 0 min (to establish a baseline level) and
20 min postspike. Following normalization to C. burnetii P311-lux, a
significant increase in light production was observed for C. burnetii
PicmW-lux and C. burnetii Pcig2-lux in the presence of cysteine and
serine (Fig. 3B). Furthermore, an upward trend for many amino
acids was observed, including alanine, aspartic acid, glutamic acid,
glycine, phenylalanine, and proline (Fig. 3B). The addition of some
of these amino acids to ACCM-2 further decreased the pH of this
acidic medium. To eliminate this variable, the same experiments
were performed using this subset of amino acids in Hepes buffer,
which mitigated the substantial acidification of ACCM-2 after amino
acid addition. The impact of several amino acids was diminished in
Hepes buffer (SI Appendix, Fig. S2F), especially cysteine, glutamic
acid, and glycine; however, a luciferase signal was still observed with
the addition of phenylalanine and aspartic acid (SI Appendix, Fig.
S2F). Given that addition of aspartic acid further acidified the media
and also severely impacted the total light produced, additional ex-
periments were performed in H2O with the nonpolar amino acid
phenylalanine to ensure signal transduction was not impacted by
altered pH beyond physiological levels (4.5 < pH > 8.0) (51).
A small but statistically robust signal increase was observed in
the presence of phenylalanine (Fig. 3C). Importantly, no increased
luciferase signal was observed in the C. burnetii pmrA::Tn strain
expressing the same luciferase reporters, indicating a direct link
between phenylalanine and PmrA/B activation (Fig. 3C). A
number of different amino acid combinations were attempted and
the most consistent, PmrA-dependent response was observed by
spiking media with phenylalanine, proline, and serine (Fig. 3C).
Finally, the impact of these three amino acids in vivo was con-
firmed. Translocation of BlaM–MceA was measured in HeLa cells
infected with C. burnetii pBlaM–MceA and simultaneously treated
with either phenylalanine alone or in combination with proline
and serine. An observable increase in effector translocation was
detected in the presence of these amino acids when compared
with H2O alone (Fig. 3D). This critical experiment highlights that
the characterization of the in vitro response to amino acids by C.
burnetii translates to a physiologically relevant increase in effector
translocation during infection.
RNA-Sequencing Analysis Reveals a Role for Amino Acids in Controlling
the PmrA/B Regulon. To elucidate the impact of amino acids on
gene regulation by the PmrA/B two-component system, tran-
scriptional profiling was performed. The amino acid combination
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of phenylalanine, proline, and serine was selected since this
combination demonstrated a robust PmrA-regulated response in
the luciferase reporter strains (Fig. 3C) and the combination of
these amino acids did not alter the pH of the media. The tran-
scriptional profiles of C. burnetii wild type (WT) and C. burnetii
pmrA::Tn, grown in axenic media for 3 d and spiked with either
H2O or the amino acid mixture for 20 min, were evaluated using
RNA-sequencing (RNA-seq) (Datasets S4–S6). Comparison
between the transcriptome of the water-treated samples and the
RNA-seq analysis published by Beare et al. (21) revealed 62
common genes significantly up-regulated in C. burnetii WT
compared with C. burnetii pmrA::Tn (SI Appendix, Table S3),
suggesting that addition of water did not impact the PmrA/B
transcriptional profile. Furthermore, this dataset identified an
additional 36 genes as PmrA-regulated, of which 10 have pre-
viously been identified as Dot/Icm effectors (SI Appendix, Table
S3). Of the 62 common genes, including genes encoding for
components of the Dot/Icm secretion system and known ef-
fectors, the log2 fold change of C. burnetii WT H2O compared
with C. burnetii pmrA::Tn H2O for this study is shown in Fig.
4A. To understand whether the presence of amino acids
changed the transcriptional profile of these 62 genes, compar-
ison between C. burnetii WT amino acids and C. burnetii WT
H2O was performed (Fig. 4B). Of the 62 genes, 42 genes (68%)
were up-regulated in the presence of amino acids. Importantly,
this up-regulation was not observed when comparing the water
and amino acid treatment of C. burnetii pmrA::Tn (Fig. 4B).
Collectively, these data demonstrate that the presence of phe-
nylalanine, proline, and serine specifically induces expression of
PmrA-regulated genes.
Discussion
Unlike other intracellular bacterial pathogens, C. burnetii, the
causative agent of human Q fever, relies on the eukaryotic host
to deliver it to a lysosomal environment. Once resident in this
normally bactericidal compartment, the pathogen activates the
Dot/Icm secretion system to remodel the organelle into a
replication-permissive environment. This study reports the global
identification of the human proteins that contribute to C. burnetii
Dot/Icm effector translocation, uncovering important details
regarding the initiation of C. burnetii virulence. Environmental
adaptation, mediated by tight control of transcription, is central
to the success of many bacterial pathogens. C. burnetii uses the
PmrA/B two-component system to sense the degradative lyso-
somal environment and induce a transcriptional shift that me-
diates virulence. The outcome of transcriptional up-regulation of
both the Dot/Icm apparatus and effector repertoire, once in the
lysosome, is the formation of the replicative CCV which expands
to occupy much of the host cell cytoplasm and support C. burnetii
replication.
The siRNA screen performed here has exploited the lysosomal
dependency of C. burnetii Dot/Icm activation to reveal many
features of the host–pathogen interaction during establishment
of C. burnetii infection. Human proteins that facilitate transport
of microbes to the lysosome and proteins that create the deg-
radative environment sensed by C. burnetii were identified in this
screen. In addition, this screen also identified host factors that
may be involved in C. burnetii invasion of HeLa cells. The C.
burnetii outer-membrane protein OmpA has a role in facilitating
C. burnetii entry of nonphagocytic cells; however, the host re-
ceptor for this invasin remains unknown (14). Likely candidates
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include integrin proteins; indeed, gene silencing of several alpha
and beta integrins led to reduced effector translocation. Silenc-
ing integrin beta-8 (ITGB8) caused the most severe defect, with a
55% reduction in effector translocation. Similarly, gene silencing
of either integrin alpha-2 or beta-1, which are known to form
heterodimers in HeLa cells (52), demonstrated a 40% drop in
effector translocation.
Transport of microbes through the endocytic pathway to the
lysosome represents a fundamental innate immune process. The
siRNA screen performed here provides validation and insight
into the human proteins that are involved in this process. Adaptor
proteins, Rab GTPases, coatomer components, SNAREs, and
VPS proteins were all validated as contributing to C. burnetii Dot/
Icm effector translocation, many presumably by contributing to
delivery of the pathogen to the lysosome. Most interestingly, this
siRNA screen demonstrated that many lysosomal proteins, in-
cluding proteases such as TPP1, contribute to C. burnetii virulence.
TMEM163, recently characterized as a lysosomal zinc transporter
(53, 54), was validated as a high-confidence hit, with one of the
most significant impacts on Dot/Icm effector translocation, likely
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due to the importance of zinc as a cofactor for lysosomal en-
zymes. Similarly, M6PR, responsible for the delivery of many
lysosomal proteins to the correct compartment, is also required
for appropriate Dot/Icm effector translocation and efficient in-
tracellular replication of C. burnetii. Overall, gene silencing 73
out of 185 known lysosomal proteins led to a reduction in Dot/
Icm effector translocation. Given the overrepresentation of ly-
sosomal proteins, the results from this screen may provide an
opportunity to discover novel lysosomal proteins.
The requirement for specific lysosomal proteases, such as
TPP1, for efficient Dot/Icm effector translocation led to the
hypothesis that C. burnetii induces the activation of the Dot/Icm
system in response to protein degradation in the lysosome. This
was supported by demonstration that increased autophagy, and
therefore increased delivery of protease substrate to the lyso-
some, causes increased Dot/Icm effector translocation in a
manner that is dependent on M6PR. Importantly, analysis of the
downstream progression of C. burnetii infection demonstrated
that loss of these proteins, and subsequent reduced Dot/Icm
translocation, does not necessarily impact CCV biogenesis and
pathogen replication. This likely indicates that infection can
progress as long as Dot/Icm effector translocation reaches a
critical threshold level. It is plausible that this observation re-
flects the permissive nature of the host cell used in these studies.
HeLa cells, with a less active lysosomal network, may still facil-
itate replication of C. burnetii with suboptimal levels of effector
delivery. However, in the predominant natural host cell, alveolar
macrophages, a more developed lysosomal compartment, would
likely further promote effector delivery but perturbation of this
compartment may have a more significant impact on infection
progression.
A series of luciferase reporter strains has allowed us to dem-
onstrate that the C. burnetii PmrA/PmrB two-component system
responds to specific amino acids that are found at high concen-
tration in the lysosome (55). The PmrA/PmrB two-component
system has been well-characterized in both L. pneumophila and
C. burnetii as controlling the expression of genes encoding for
structural components of the Dot/Icm apparatus and a large
subset of Dot/Icm effectors (13, 20, 21, 56, 57). Given this tran-
scriptional influence, it is not surprising that this two-component
system is required for intracellular growth of both pathogens (13,
20, 21). The PmrB sensor histidine kinases of L. pneumophila and
C. burnetii share 50% identity across the entire protein and are
highly conserved within the histidine kinase domain. Importantly,
the predicted extracellular component of PmrB that recognizes en-
vironmental signals is the least conserved region, supporting the hy-
pothesis that these proteins respond to different extracellular stimuli.
Homologous PmrA/PmrB two-component systems have been
well-characterized in a range of bacterial species and have been
shown to contribute to virulence of several pathogens including
Salmonella enterica serovar Typhimurium and Pseudomonas
aeruginosa (reviewed in ref. 50). In these bacteria, environmental
stimuli such as low Mg2+ or high Fe3+ are recognized by PmrB,
leading to activation of the response regulator PmrA and tran-
scriptional changes that promote LPS alterations to facilitate
resistance to antibiotics such as polymyxin B and to toxic metals
such as Fe3+ (58, 59).
Initial characterization of the C. burnetii luciferase reporters
used here demonstrated that the C. burnetii PmrA/PmrB system
does not respond to these stimuli. Rather, we have demonstrated
that C. burnetii PmrB can sense amino acids, particularly phe-
nylalanine, proline, and serine, to induce activation of PmrA.
The recent first comprehensive analysis of metabolites in the
lysosome demonstrates the presence of these amino acids used
here to induce a PmrA-dependent transcriptional response (55).
Characterization of the lysosomemetabolome has also demonstrated
that the oxidized form of cysteine, cystine, represents a defining
characteristic of the lysosome, with a 28-fold higher concentration
in the lysosome compared with the rest of the human cell (55).
Abu-Remaileh et al. (55) also demonstrated that vATPase inhi-
bition leads to a significant decrease in lysosomal cystine, sup-
porting our previous observations that low lysosomal pH is
required for C. burnetii Dot/Icm function (18). Interestingly, our
data indicate that Dot/Icm function may also be inhibited by un-
usually high concentrations of particular amino acids as the
siRNA screen demonstrated an effector translocation defect for
several amino acid transporters including cystinosin, the lysosomal
cystine transporter (CTNS) which exports cystine to the cytosol.
Sensing and responding to amino acids is not restricted to C.
burnetii. The recently characterized GluR-GluK two-component
system of Streptomyces coelicolor responds to extracellular glu-
tamate to increase expression of a glutamate uptake system (60).
This response allows a transcriptional shift that can impact
metabolic activity in response to nutrient availability. In contrast,
the PmrA/B response of C. burnetii is not linked to metabolic
changes but to transition to a virulent phenotype. Transcriptional
virulence induction in response to amino acids also appears true
for enterohemorrhagic Escherichia coli (EHEC) as a recent re-
port indicated that exogenous cysteine can be sensed by the
EHEC cysteine utilization regulator CutR, leading to increased
expression of genes within the virulence-associated locus of the
enterocyte effacement pathogenicity island (61).
Specific two-component systems can respond to more than
one stimulus (50, 62). Thus, further investigation may demon-
strate that other lysosomal breakdown products also stimulate C.
burnetii PmrA/PmrB activity, particularly given that silencing of
MANBA and lysosomal sialidase (NEU1) both reduced C. bur-
netii Dot/Icm effector translocation. This study has significantly
broadened our understanding of C. burnetii pathogenesis and the
intimate relationships between intracellular bacterial virulence
and their subcellular niche.
Materials and Methods
Data Availability Statement. The complete siRNA screen data is available in
Dataset S1. All RNA-seq data is available in Datasets S4–S6.
Cell Culture. HeLa cells were maintained in Dulbecco’s modified Eagle’s
medium (GlutaMAX; Gibco) supplemented with 10% heat-inactivated FBS at
37 °C in 5% CO2.
Bacterial Strains. C. burnetii Nine Mile phase II (RSA439, clone 4) strains were
cultured axenically in ACCM-2 at 37 °C in 5% CO2 and 2.5% O2 (63). Chlor-
amphenicol and kanamycin were added to ACCM-2 at 3 and 350 μg/mL,
respectively, when required. E. coli DH5α, E. coli PIR1, or E. coli PIR2 strains
were grown in Luria-Bertani (LB) broth or on LB agar plates containing
ampicillin (100 μg/mL), chloramphenicol (12.5 μg/mL), or kanamycin (100 μg/mL)
as necessary.
High-Throughput siRNA Screening. HeLa cells (3,920 cells per well) were
reverse-transfected in black-walled clear-bottom 96-well plates (Corning)
with siGENOME SMARTpool siRNAs (final concentration 40 nM) using
DharmaFECT 1 lipid transfection reagent (0.1 μL per well) (Dharmacon RNAi
Technologies). Genome-wide siRNA libraries (catalog numbers in Dataset S1)
were screened at the Victorian Centre for Functional Genomics at the Peter
MacCallum Cancer Centre. Each well in the siGENOME SMARTpool siRNA
library contained 4 siRNAs targeting different sequences of the target
transcript. A deconvolution validation screen was performed using the in-
dividual siRNA duplexes, all four on the same library plate (catalog numbers
in Dataset S2) at 25 nM with the same assay conditions as above.
Cells were reverse-transfected using the SciClone ALH3000 lab automation
liquid handler (Caliper Life Sciences) and EL406 microplate washer dispenser
(BioTek). Cells were transfected in duplicate and media were changed 24 h
after transfection using the EL406 microplane washer dispenser (BioTek).
Seventy-two hours posttransfection, cells were infected with C. burnetii
pBlaM–MceA at a multiplicity of infection (MOI) of 300 for 24 h. Infected
cells were loaded with CCF2-AM using the LiveBLAzer FRET B/G Loading Kit
(Invitrogen) and 0.1 M probenecid. The CLARIOstar microplate reader (BMG
LABTECH) was used to quantify translocation. The ratio of 450 nm (blue;
product in Dataset S1) to 520 nm (green; substrate in Dataset S1) was
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calculated. Cell viability was determined by fixing (4% paraformaldehyde
for 15 min) and staining cells with DRAQ5 fluorescent probe solution
(Thermo Scientific; 1:4,000 in PBS). A CellInsight High-Content Screening
microscope (Thermo Scientific) was used to quantify the number of nuclei
per well for nine fields using a 5× objective alongside the Target Activation
bioapplication of HCS Studio cell analysis software (iDev workflow). Details
of the bioinformatic analysis of siRNA screen data are described in SI Ap-
pendix, Materials and Methods.
Generation of CRISPR Cell Lines. CRISPR-Cas9 genome editing was performed
using pX459 v2.0, a gift from Feng Zhang (Addgene plasmid 62988). Guide
RNA specific for LRP1 (64), M6PR, and TPP1 (designed using https://zlab.bio/
guide-design-resources; SI Appendix, Table S4) was cloned into pX459 (65).
HeLa cells were seeded at 3.75 × 105 per well in six-well tissue-culture plates
and cotransfected using Lipofectamine 3000 and a total of 2,500 ng DNA
specific to either one exon (LRP1) or two exons (M6PR and TPP1). Cells were
selected with puromycin (2.5 μg/mL) and clonally isolated in 96-well tissue-
culture plates.
Generation of Luciferase-Expressing C. burnetii Strains. Integration plasmids
[pMiniTn7T-Kan and pMiniTn7T-CAT::luxCDABE (21)] were a gift from
P. Beare (Rocky Mountain Laboratories, NIH, Hamilton, MT). The luxCDABE
operon, T0T1 terminator, and promoters amplified from C. burnetii genomic
DNA were added to pMiniTn7T as described in SI Appendix, Table S4. The
integration of the luciferase-expressing plasmids into C. burnetii WT and C.
burnetii pmrA::Tn was achieved by electroporation and selection as de-
scribed previously (10, 66). Luciferase-expressing C. burnetii were analyzed
for a response to pH or altered medium composition as described in SI Ap-
pendix, Materials and Methods.
Amino Acid Analysis. The 20 essential amino acids were diluted in either dH2O
or 1 M Hepes buffer to a final concentration of 100 mM. Axenically grown C.
burnetii strains were added to white-bottomed 96-well tissue-culture plates
at 1 × 105 GE (genome equivalent) per well and incubated at 37 °C with 5%
CO2 and 2.5% O2 for 72 h. Amino acids were added at a final concentration
of 10 mM (or equal volume of carrier) to individual wells in duplicate. The
plates were then incubated at 37 °C for 20 min using the CLARIOstar
microplate reader in which light production was measured at 0 min (to
provide a baseline measurement) and 20 min after the addition of amino
acids. Light production values of PicmW and Pcig2 strains were adjusted
relative to P311 following normalization to carrier-treated samples.
DQ-BSA Assay. DQ Green BSA (Life Technologies) was used to measure ly-
sosomal protease activity in cells as described previously (67), with slight
modifications described in SI Appendix, Materials and Methods.
RNA-Seq Analysis. C. burnetii WT and C. burnetii pmrA::Tn were grown
axenically for 7 d in quadruplicate and subsequently inoculated in duplicate
into 30 mL ACCM-2 at a concentration of 1 × 106 GE per mL. Bacteria were
grown in ACCM-2 for 72 h, after which each strain was treated with either
dH2O or an amino acid mixture consisting of 10 mM phenylalanine, 10 mM
proline, and 10 mM serine and incubated at 37 °C in 5% CO2 and 2.5% O2 for
a further 20 min. Cultures were harvested at 3,250 × g for 15 min at 4 °C and
RNA was extracted using TRIsure (Bioline) according to the manufacturer’s
instructions. Samples were treated for DNA contamination using an RNase-
Free DNase Set (QIAGEN) and cleaned using the RNease Mini Kit (QIAGEN) as
per the manufacturer’s instructions.
High-quality RNA samples, as assessed on an Agilent 2100 Bioanalyzer,
were submitted to the Australian Genome Research Facility for ribosomal
RNA depletion using Ribo-Zero bacteria (Illumina) and high-throughput 100-bp
single-end sequencing on the IlluminaHiSeq 2500. Transcripts were analyzed as
described in SI Appendix, Materials and Methods.
Please refer to SI Appendix,Materials and Methods for more information
regarding siRNA transfections, translocation assays, real-time quantification,
Western blot analysis, C. burnetii infections, immunofluorescence staining,
microscopy, and statistical analysis.
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